Back
Eagle Pharmaceuticals Stock Price Chart
Trump's "Document 20" Revealed: Smart Americans Could Get Rich During His 2nd Term
See if stocks could soar as much as 1,000% if history repeats itself.
Sell
17
EGRX
Eagle Pharmaceuticals
Last Price:
0.70
Seasonality Move:
-6.88%
7 Day Trial
ALL ACCESS PASS
$
7
America's enemies are regrouping & it may sucker punch your savings
Click here to learn more.- Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EGRX is experiencing selling pressure, which indicates risk of future bearish movement.
Eagle Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 0.81 | Sell |
| 20-day SMA: | 0.68 | Buy |
| 50-day SMA: | 2.01 | Sell |
| 200-day SMA: | 4.22 | Sell |
| 8-day EMA: | 0.76 | Sell |
| 20-day EMA: | 0.88 | Sell |
| 50-day EMA: | 1.79 | Sell |
| 200-day EMA: | 4.99 | Sell |
Eagle Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.28 | Sell |
| Relative Strength Index (14 RSI): | 38.76 | Sell |
| Chaikin Money Flow: | -85095 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (0.53 - 0.83) | Buy |
| Bollinger Bands (100): | (1.57 - 5.49) | Sell |
Eagle Pharmaceuticals Technical Analysis
| Nov 1 | Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov | ||||||||||
| 01 | 04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Eagle Pharmaceuticals Stock
Is Eagle Pharmaceuticals Stock a Buy?
- Eagle Pharmaceuticals share price is 0.70 while EGRX 8-day simple moving average is 0.81, which is a Sell signal.
- The stock price of EGRX is 0.70 while Eagle Pharmaceuticals 20-day SMA is 0.68, which makes it a Buy.
- Eagle Pharmaceuticals 50-day simple moving average is 2.01 while EGRX share price is 0.70, making it a Sell technically.
- EGRX stock price is 0.70 and Eagle Pharmaceuticals 200-day simple moving average is 4.22, creating a Sell signal.
EGRX Technical Analysis vs Fundamental Analysis
Sell
17
Eagle Pharmaceuticals (EGRX)
is a Sell
Is Eagle Pharmaceuticals a Buy or a Sell?
-
Eagle Pharmaceuticals stock is rated a Sell
The current Eagle Pharmaceuticals [EGRX] share price is $0.70. The Score for EGRX is 17, which is 66% below its historic median score of 50, and infers higher risk than normal.
Eagle Pharmaceuticals Stock Info
Market Cap:
9.1M
Price in USD:
0.70
Share Volume:
85.38K
Eagle Pharmaceuticals 52-Week Range
52-Week High:
9.10
52-Week Low:
0.00
Sell
17
Eagle Pharmaceuticals (EGRX)
is a Sell
Eagle Pharmaceuticals Share Price Forecast
-
What is the Eagle Pharmaceuticals stock price today?
The Eagle Pharmaceuticals stock price is 0.70 USD today. -
Will EGRX stock go up or go down?
Eagle Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Eagle Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Eagle Pharmaceuticals is overvalued.
Is Eagle Pharmaceuticals Stock a Buy?
- Eagle Pharmaceuticals share price is 0.70 while EGRX 8-day exponential moving average is 0.76, which is a Sell signal.
- The stock price of EGRX is 0.70 while Eagle Pharmaceuticals 20-day EMA is 0.88, which makes it a Sell.
- Eagle Pharmaceuticals 50-day exponential moving average is 1.79 while EGRX share price is 0.70, making it a Sell technically.
- EGRX stock price is 0.70 and Eagle Pharmaceuticals 200-day simple moving average is 4.99, creating a Sell signal.
Fundamental Analysis of Eagle Pharmaceuticals
Is Eagle Pharmaceuticals a good investment?
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.94 per share, and a decrease next year of $0.00 per share.
Technical Analysis of Eagle Pharmaceuticals
Should I short Eagle Pharmaceuticals stock?
- EGRX Moving Average Covergence Divergence (MACD) indicator is -0.28, suggesting Eagle Pharmaceuticals is a Sell
- Eagle Pharmaceuticals Relative Strength Index (RSI) is 38.76, which suggest Eagle Pharmaceuticals is oversold
- The Bollinger Bands (25) for Eagle Pharmaceuticals is (0.53 - 0.83), which suggest Eagle Pharmaceuticals is a Sell
- The Bollinger Bands (100) for Eagle Pharmaceuticals is (1.57 - 5.49), which suggest Eagle Pharmaceuticals is a Sell
* Eagle Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.